Cardiothoracic & vascular anesthesia

Prophylactic Dexmedetomidine Reduces Junctional Ectopic Tachycardia and Facilitates Postoperative Recovery in Pediatric Cardiac Surgery: A Systematic Review and Meta‐Analysis of Prospective Trials

Paediatr AnaesthPublished Systematic review and meta-analysis of prospective trials

Pooled result · Postoperative JET incidenceResult — go to the resultOdds ratio 0.37 95% CI 0.23–0.58

Authors' conclusion

In prospective pediatric cardiac surgery trials, prophylactic dexmedetomidine was associated with reduced postoperative JET, supported by moderate-certainty evidence.

Study context

Population
Children undergoing congenital heart surgery
Participants
639 children · 5 prospective trials
Comparison
Prophylactic dexmedetomidine vs control
Outcome
Postoperative Junctional Ectopic Tachycardia (JET) incidence
Methodological detailsrandomized and quasi-randomized trials, random-effects models, GRADE
  • Randomized and quasi-randomized trials
  • Random-effects models
  • GRADE

Pooled result

As reported in the abstract

Odds ratio

0.37

95% CI 0.23–0.58

P < 0.0001

Dexmedetomidine vs Control
OR 0.37 (95% CI 0.23–0.58); P < 0.0001

Further pooled results

OutcomeMD (h)
Mechanical ventilation durationDexmedetomidine vs Control · substantial clinical heterogeneity · low to very-low certainty of evidence−4.80
ICU LOSDexmedetomidine vs Control · substantial clinical heterogeneity · low to very-low certainty of evidence−19.83

Vasoactive-Inotropic Score (VIS)

Significant reduction in VIS only in the sensitivity analysis; hypothesis-generating

Mortality and hypotension

No significant differences

Original publication

Prophylactic Dexmedetomidine Reduces Junctional Ectopic Tachycardia and Facilitates Postoperative Recovery in Pediatric Cardiac Surgery: A Systematic Review and Meta‐Analysis of Prospective Trials. Paediatr Anaesth. Published 8 April 2026. doi:10.1002/pan.70182

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.